New 2027–2030 strategy marks a pivotal shift from early-stage scientific discovery toward bringing promising treatments to people with CF. PHILADELPHIA, PA—November 18, 2026—Emily’s Entourage (EE), an innovative 501(c)(3) organization accelerating research for individuals with cystic fibrosis (CF) who do not benefit from current mutation-targeted therapies, announced its ambitious 2027–2030 Research Roadmap, a strategic blueprint to... Read More
https://www.emilysentourage.org/emilys-entourage-announces-bold-research-roadmap-to-accelerate-breakthroughs-for-the-final-10-of-people-with-cystic-fibrosis/